AI solutions baked into the EHR experience could radically transform the clinical effectiveness of physicians by leveraging the richness of the longitudinal patient record, while also creating efficiencies that give them back more time to care and create more revenue. The post From Paper Charts to AI Scribes: The EHR Revolution appeared first on MedCity…
Contrary to fears of clinician replacement, AI’s near-term potential lies in complementing human expertise, particularly by handling behind-the-scenes tasks that improve efficiency and precision. Here’s where we might see the most impact. The post The Near-Term Future of AI in Health Care appeared first on MedCity News.
Providence spun off its venture capital arm and renamed it Allumia Ventures. The newly independent venture capital firm also recently closed its third fund, in which Providence invested $150 million. Allumia is looking to grow the fund by inviting 3-5 other health systems to be limited partner investors. The post Providence Spun Out Its VC…
Missed the January 15 deadline for 2025 Marketplace Open Enrollment? Don’t worry—you may still have options for health coverage for the rest of the year. Image Enroll with a Special Enrollment Period You could be eligible for a Special Enrollment Period to get or change your health coverage if: Your income is within a certain…
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report examines the impact of PBMs (specifically CVS Caremark, Express Scripts and Optum Rx) on specialty generic drugs, highlighting substantial price markups by PBMs on medications for cancer, HIV and other conditions. The post Healthcare Leaders Support FTC’s…
The good news is that virtual solutions are becoming more sophisticated every day to eliminate these care deserts. These promising strategies are helping. The post Tech-driven Heart Care Key to Cardiology Desert Crisis appeared first on MedCity News.
AI/big data haven’t solved healthcare’s challenges. Despite advancements, systemic barriers persist, but AI offers potential to improve outcomes and efficiency. The post Is ‘Big Data’ the Cure-all for U.S. Healthcare? appeared first on MedCity News.
Combining AI-driven insights with tailored care pathways, patients gain access to health coaches, psychologists, and treatment plans, while providers benefit from workflow optimization. The post GVX Venture Studio Launches FusionCare.AI: A One-Stop Shop for Obesity Care at the Future and Health Executive Summit at JPM 2025 appeared first on MedCity News.
Revenue for the blockbuster Eli Lilly drugs Mounjaro and Zepbound continues to grow, but not as much as expected. At the J.P. Morgan Healthcare Conference, Lilly CEO David Ricks explained why the company revised downward its projections for fourth quarter 2024 revenue. The post At JPM, Eli Lilly’s CEO Explains Why Mounjaro, Zepbound Sales Were…
More than a decade ago, Medtronic announced that a pivotal trial testing its renal denervation system had failed. Though it got approved later, reimbursement has been elusive. All that might change this year. The post Is Medtronic On the Cusp of Rewriting the Story of Renal Denervation? appeared first on MedCity News.